nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—ABCG2—Omeprazole—Barrett's esophagus	0.147	0.314	CbGbCtD
Nilotinib—CYP2C8—Omeprazole—Barrett's esophagus	0.0782	0.167	CbGbCtD
Nilotinib—CYP2C9—Omeprazole—Barrett's esophagus	0.0545	0.117	CbGbCtD
Nilotinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0538	0.115	CbGbCtD
Nilotinib—ABCB1—Omeprazole—Barrett's esophagus	0.0529	0.113	CbGbCtD
Nilotinib—CYP2D6—Omeprazole—Barrett's esophagus	0.0498	0.107	CbGbCtD
Nilotinib—CYP3A4—Omeprazole—Barrett's esophagus	0.0317	0.0678	CbGbCtD
Nilotinib—MAPK8—exocrine gland—Barrett's esophagus	0.0094	0.0812	CbGeAlD
Nilotinib—CA6—exocrine gland—Barrett's esophagus	0.00675	0.0583	CbGeAlD
Nilotinib—CDC42BPB—smooth muscle tissue—Barrett's esophagus	0.00436	0.0376	CbGeAlD
Nilotinib—MAPK8—epithelium—Barrett's esophagus	0.00409	0.0353	CbGeAlD
Nilotinib—MAPK8—smooth muscle tissue—Barrett's esophagus	0.00394	0.034	CbGeAlD
Nilotinib—KIT—exocrine gland—Barrett's esophagus	0.00392	0.0339	CbGeAlD
Nilotinib—EPHB2—digestive system—Barrett's esophagus	0.00389	0.0336	CbGeAlD
Nilotinib—TIE1—epithelium—Barrett's esophagus	0.00354	0.0306	CbGeAlD
Nilotinib—CDC42BPB—digestive system—Barrett's esophagus	0.00344	0.0297	CbGeAlD
Nilotinib—TIE1—smooth muscle tissue—Barrett's esophagus	0.00342	0.0295	CbGeAlD
Nilotinib—MAPK8—digestive system—Barrett's esophagus	0.00311	0.0269	CbGeAlD
Nilotinib—MAPK14—epithelium—Barrett's esophagus	0.0026	0.0224	CbGeAlD
Nilotinib—EPHB3—digestive system—Barrett's esophagus	0.00256	0.0222	CbGeAlD
Nilotinib—MAPK14—smooth muscle tissue—Barrett's esophagus	0.0025	0.0216	CbGeAlD
Nilotinib—EPHB4—epithelium—Barrett's esophagus	0.00246	0.0213	CbGeAlD
Nilotinib—EPHA2—epithelium—Barrett's esophagus	0.00241	0.0209	CbGeAlD
Nilotinib—EPHB4—smooth muscle tissue—Barrett's esophagus	0.00237	0.0205	CbGeAlD
Nilotinib—HCK—digestive system—Barrett's esophagus	0.00236	0.0204	CbGeAlD
Nilotinib—TEK—epithelium—Barrett's esophagus	0.00236	0.0203	CbGeAlD
Nilotinib—CA2—exocrine gland—Barrett's esophagus	0.00232	0.0201	CbGeAlD
Nilotinib—CA7—digestive system—Barrett's esophagus	0.00231	0.0199	CbGeAlD
Nilotinib—TEK—smooth muscle tissue—Barrett's esophagus	0.00227	0.0196	CbGeAlD
Nilotinib—PDGFRA—smooth muscle tissue—Barrett's esophagus	0.00206	0.0178	CbGeAlD
Nilotinib—CA9—digestive system—Barrett's esophagus	0.00203	0.0175	CbGeAlD
Nilotinib—MAPK14—digestive system—Barrett's esophagus	0.00198	0.0171	CbGeAlD
Nilotinib—FGR—digestive system—Barrett's esophagus	0.00197	0.017	CbGeAlD
Nilotinib—EPHB4—digestive system—Barrett's esophagus	0.00187	0.0162	CbGeAlD
Nilotinib—EPHA2—digestive system—Barrett's esophagus	0.00184	0.0159	CbGeAlD
Nilotinib—CSF1R—smooth muscle tissue—Barrett's esophagus	0.00181	0.0156	CbGeAlD
Nilotinib—KIT—epithelium—Barrett's esophagus	0.00171	0.0147	CbGeAlD
Nilotinib—PDGFRB—epithelium—Barrett's esophagus	0.00167	0.0144	CbGeAlD
Nilotinib—KIT—smooth muscle tissue—Barrett's esophagus	0.00164	0.0142	CbGeAlD
Nilotinib—PDGFRA—digestive system—Barrett's esophagus	0.00162	0.014	CbGeAlD
Nilotinib—PDGFRB—smooth muscle tissue—Barrett's esophagus	0.00161	0.0139	CbGeAlD
Nilotinib—UGT1A1—digestive system—Barrett's esophagus	0.00155	0.0134	CbGeAlD
Nilotinib—CA12—digestive system—Barrett's esophagus	0.0015	0.0129	CbGeAlD
Nilotinib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00143	0.0124	CbGeAlD
Nilotinib—CSF1R—digestive system—Barrett's esophagus	0.00143	0.0123	CbGeAlD
Nilotinib—Dry eye—Omeprazole—Barrett's esophagus	0.00133	0.00495	CcSEcCtD
Nilotinib—Dry eye—Esomeprazole—Barrett's esophagus	0.00133	0.00495	CcSEcCtD
Nilotinib—Mouth ulceration—Omeprazole—Barrett's esophagus	0.0013	0.00484	CcSEcCtD
Nilotinib—Neoplasm—Esomeprazole—Barrett's esophagus	0.0013	0.00484	CcSEcCtD
Nilotinib—Neoplasm—Omeprazole—Barrett's esophagus	0.0013	0.00484	CcSEcCtD
Nilotinib—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.0013	0.00484	CcSEcCtD
Nilotinib—KIT—digestive system—Barrett's esophagus	0.0013	0.0112	CbGeAlD
Nilotinib—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00129	0.00479	CcSEcCtD
Nilotinib—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00129	0.00479	CcSEcCtD
Nilotinib—PDGFRB—digestive system—Barrett's esophagus	0.00127	0.011	CbGeAlD
Nilotinib—Ear pain—Esomeprazole—Barrett's esophagus	0.00122	0.00456	CcSEcCtD
Nilotinib—Ear pain—Omeprazole—Barrett's esophagus	0.00122	0.00456	CcSEcCtD
Nilotinib—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.0012	0.00447	CcSEcCtD
Nilotinib—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.0012	0.00447	CcSEcCtD
Nilotinib—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00119	0.00445	CcSEcCtD
Nilotinib—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00119	0.00445	CcSEcCtD
Nilotinib—Photosensitivity—Omeprazole—Barrett's esophagus	0.00119	0.00443	CcSEcCtD
Nilotinib—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00119	0.00443	CcSEcCtD
Nilotinib—CA1—digestive system—Barrett's esophagus	0.00119	0.0103	CbGeAlD
Nilotinib—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00118	0.00439	CcSEcCtD
Nilotinib—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00118	0.00439	CcSEcCtD
Nilotinib—ABL1—digestive system—Barrett's esophagus	0.00113	0.00976	CbGeAlD
Nilotinib—Increased appetite—Esomeprazole—Barrett's esophagus	0.00111	0.00414	CcSEcCtD
Nilotinib—Increased appetite—Omeprazole—Barrett's esophagus	0.00111	0.00414	CcSEcCtD
Nilotinib—Arthritis—Omeprazole—Barrett's esophagus	0.00107	0.004	CcSEcCtD
Nilotinib—Arthritis—Esomeprazole—Barrett's esophagus	0.00107	0.004	CcSEcCtD
Nilotinib—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00107	0.00398	CcSEcCtD
Nilotinib—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00107	0.00398	CcSEcCtD
Nilotinib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00105	0.0039	CcSEcCtD
Nilotinib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00105	0.0039	CcSEcCtD
Nilotinib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00104	0.00389	CcSEcCtD
Nilotinib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00104	0.00389	CcSEcCtD
Nilotinib—Diplopia—Esomeprazole—Barrett's esophagus	0.00104	0.00389	CcSEcCtD
Nilotinib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00104	0.00389	CcSEcCtD
Nilotinib—Diplopia—Omeprazole—Barrett's esophagus	0.00104	0.00389	CcSEcCtD
Nilotinib—Pain in extremity—Omeprazole—Barrett's esophagus	0.00104	0.00389	CcSEcCtD
Nilotinib—Migraine—Esomeprazole—Barrett's esophagus	0.00103	0.00383	CcSEcCtD
Nilotinib—Migraine—Omeprazole—Barrett's esophagus	0.00103	0.00383	CcSEcCtD
Nilotinib—CA2—epithelium—Barrett's esophagus	0.00101	0.00874	CbGeAlD
Nilotinib—Face oedema—Esomeprazole—Barrett's esophagus	0.00101	0.00375	CcSEcCtD
Nilotinib—Face oedema—Omeprazole—Barrett's esophagus	0.00101	0.00375	CcSEcCtD
Nilotinib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000978	0.00364	CcSEcCtD
Nilotinib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000978	0.00364	CcSEcCtD
Nilotinib—CA2—smooth muscle tissue—Barrett's esophagus	0.000974	0.00842	CbGeAlD
Nilotinib—Dry skin—Esomeprazole—Barrett's esophagus	0.000957	0.00356	CcSEcCtD
Nilotinib—Dry skin—Omeprazole—Barrett's esophagus	0.000957	0.00356	CcSEcCtD
Nilotinib—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000953	0.00355	CcSEcCtD
Nilotinib—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000953	0.00355	CcSEcCtD
Nilotinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00095	0.00354	CcSEcCtD
Nilotinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00095	0.00354	CcSEcCtD
Nilotinib—Breast disorder—Esomeprazole—Barrett's esophagus	0.000943	0.00351	CcSEcCtD
Nilotinib—Breast disorder—Omeprazole—Barrett's esophagus	0.000943	0.00351	CcSEcCtD
Nilotinib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00094	0.0035	CcSEcCtD
Nilotinib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00094	0.0035	CcSEcCtD
Nilotinib—CA4—digestive system—Barrett's esophagus	0.000928	0.00802	CbGeAlD
Nilotinib—Gastritis—Omeprazole—Barrett's esophagus	0.000924	0.00344	CcSEcCtD
Nilotinib—Gastritis—Esomeprazole—Barrett's esophagus	0.000924	0.00344	CcSEcCtD
Nilotinib—Muscular weakness—Omeprazole—Barrett's esophagus	0.000921	0.00343	CcSEcCtD
Nilotinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000921	0.00343	CcSEcCtD
Nilotinib—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000921	0.00343	CcSEcCtD
Nilotinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000921	0.00343	CcSEcCtD
Nilotinib—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000908	0.00338	CcSEcCtD
Nilotinib—Abdominal distension—Omeprazole—Barrett's esophagus	0.000908	0.00338	CcSEcCtD
Nilotinib—Influenza—Omeprazole—Barrett's esophagus	0.000902	0.00336	CcSEcCtD
Nilotinib—Influenza—Esomeprazole—Barrett's esophagus	0.000902	0.00336	CcSEcCtD
Nilotinib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000884	0.00329	CcSEcCtD
Nilotinib—Pancreatitis—Omeprazole—Barrett's esophagus	0.000884	0.00329	CcSEcCtD
Nilotinib—Angina pectoris—Omeprazole—Barrett's esophagus	0.000879	0.00327	CcSEcCtD
Nilotinib—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000879	0.00327	CcSEcCtD
Nilotinib—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000857	0.00319	CcSEcCtD
Nilotinib—Pancytopenia—Omeprazole—Barrett's esophagus	0.000857	0.00319	CcSEcCtD
Nilotinib—Dysuria—Omeprazole—Barrett's esophagus	0.000844	0.00314	CcSEcCtD
Nilotinib—Dysuria—Esomeprazole—Barrett's esophagus	0.000844	0.00314	CcSEcCtD
Nilotinib—Neutropenia—Esomeprazole—Barrett's esophagus	0.000844	0.00314	CcSEcCtD
Nilotinib—Neutropenia—Omeprazole—Barrett's esophagus	0.000844	0.00314	CcSEcCtD
Nilotinib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000838	0.00312	CcSEcCtD
Nilotinib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000838	0.00312	CcSEcCtD
Nilotinib—Pollakiuria—Omeprazole—Barrett's esophagus	0.000833	0.0031	CcSEcCtD
Nilotinib—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000833	0.0031	CcSEcCtD
Nilotinib—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000831	0.00309	CcSEcCtD
Nilotinib—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000831	0.00309	CcSEcCtD
Nilotinib—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000823	0.00307	CcSEcCtD
Nilotinib—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000823	0.00307	CcSEcCtD
Nilotinib—Weight increased—Omeprazole—Barrett's esophagus	0.000821	0.00306	CcSEcCtD
Nilotinib—Weight increased—Esomeprazole—Barrett's esophagus	0.000821	0.00306	CcSEcCtD
Nilotinib—Weight decreased—Esomeprazole—Barrett's esophagus	0.000816	0.00304	CcSEcCtD
Nilotinib—Weight decreased—Omeprazole—Barrett's esophagus	0.000816	0.00304	CcSEcCtD
Nilotinib—Infestation—Esomeprazole—Barrett's esophagus	0.000804	0.003	CcSEcCtD
Nilotinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000804	0.003	CcSEcCtD
Nilotinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.000804	0.003	CcSEcCtD
Nilotinib—Infestation—Omeprazole—Barrett's esophagus	0.000804	0.003	CcSEcCtD
Nilotinib—Renal failure—Esomeprazole—Barrett's esophagus	0.000791	0.00294	CcSEcCtD
Nilotinib—Renal failure—Omeprazole—Barrett's esophagus	0.000791	0.00294	CcSEcCtD
Nilotinib—Stomatitis—Omeprazole—Barrett's esophagus	0.000784	0.00292	CcSEcCtD
Nilotinib—Jaundice—Esomeprazole—Barrett's esophagus	0.000784	0.00292	CcSEcCtD
Nilotinib—Jaundice—Omeprazole—Barrett's esophagus	0.000784	0.00292	CcSEcCtD
Nilotinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.000784	0.00292	CcSEcCtD
Nilotinib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000782	0.00291	CcSEcCtD
Nilotinib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000782	0.00291	CcSEcCtD
Nilotinib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000782	0.00291	CcSEcCtD
Nilotinib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000782	0.00291	CcSEcCtD
Nilotinib—CA2—digestive system—Barrett's esophagus	0.000769	0.00665	CbGeAlD
Nilotinib—Haematuria—Omeprazole—Barrett's esophagus	0.000767	0.00286	CcSEcCtD
Nilotinib—Haematuria—Esomeprazole—Barrett's esophagus	0.000767	0.00286	CcSEcCtD
Nilotinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000761	0.00283	CcSEcCtD
Nilotinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000761	0.00283	CcSEcCtD
Nilotinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.000759	0.00283	CcSEcCtD
Nilotinib—Epistaxis—Omeprazole—Barrett's esophagus	0.000759	0.00283	CcSEcCtD
Nilotinib—Bradycardia—Omeprazole—Barrett's esophagus	0.000735	0.00274	CcSEcCtD
Nilotinib—Bradycardia—Esomeprazole—Barrett's esophagus	0.000735	0.00274	CcSEcCtD
Nilotinib—Rhinitis—Esomeprazole—Barrett's esophagus	0.000724	0.0027	CcSEcCtD
Nilotinib—Rhinitis—Omeprazole—Barrett's esophagus	0.000724	0.0027	CcSEcCtD
Nilotinib—Hepatitis—Esomeprazole—Barrett's esophagus	0.000722	0.00269	CcSEcCtD
Nilotinib—Hepatitis—Omeprazole—Barrett's esophagus	0.000722	0.00269	CcSEcCtD
Nilotinib—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000718	0.00268	CcSEcCtD
Nilotinib—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000718	0.00268	CcSEcCtD
Nilotinib—Pharyngitis—Omeprazole—Barrett's esophagus	0.000717	0.00267	CcSEcCtD
Nilotinib—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000717	0.00267	CcSEcCtD
Nilotinib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000713	0.00266	CcSEcCtD
Nilotinib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000713	0.00266	CcSEcCtD
Nilotinib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000711	0.00265	CcSEcCtD
Nilotinib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000711	0.00265	CcSEcCtD
Nilotinib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00071	0.00264	CcSEcCtD
Nilotinib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00071	0.00264	CcSEcCtD
Nilotinib—Urethral disorder—Omeprazole—Barrett's esophagus	0.000708	0.00264	CcSEcCtD
Nilotinib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000708	0.00264	CcSEcCtD
Nilotinib—Visual impairment—Omeprazole—Barrett's esophagus	0.000696	0.00259	CcSEcCtD
Nilotinib—Visual impairment—Esomeprazole—Barrett's esophagus	0.000696	0.00259	CcSEcCtD
Nilotinib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000683	0.00254	CcSEcCtD
Nilotinib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000683	0.00254	CcSEcCtD
Nilotinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.000675	0.00251	CcSEcCtD
Nilotinib—Eye disorder—Omeprazole—Barrett's esophagus	0.000675	0.00251	CcSEcCtD
Nilotinib—Tinnitus—Omeprazole—Barrett's esophagus	0.000673	0.00251	CcSEcCtD
Nilotinib—Tinnitus—Esomeprazole—Barrett's esophagus	0.000673	0.00251	CcSEcCtD
Nilotinib—Flushing—Omeprazole—Barrett's esophagus	0.00067	0.0025	CcSEcCtD
Nilotinib—Flushing—Esomeprazole—Barrett's esophagus	0.00067	0.0025	CcSEcCtD
Nilotinib—CYP2B6—digestive system—Barrett's esophagus	0.000657	0.00568	CbGeAlD
Nilotinib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000652	0.00243	CcSEcCtD
Nilotinib—Immune system disorder—Omeprazole—Barrett's esophagus	0.000652	0.00243	CcSEcCtD
Nilotinib—CYP2C9—digestive system—Barrett's esophagus	0.000651	0.00562	CbGeAlD
Nilotinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000651	0.00242	CcSEcCtD
Nilotinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000651	0.00242	CcSEcCtD
Nilotinib—Chills—Esomeprazole—Barrett's esophagus	0.000648	0.00241	CcSEcCtD
Nilotinib—Chills—Omeprazole—Barrett's esophagus	0.000648	0.00241	CcSEcCtD
Nilotinib—Alopecia—Esomeprazole—Barrett's esophagus	0.000638	0.00238	CcSEcCtD
Nilotinib—Alopecia—Omeprazole—Barrett's esophagus	0.000638	0.00238	CcSEcCtD
Nilotinib—Mental disorder—Esomeprazole—Barrett's esophagus	0.000633	0.00236	CcSEcCtD
Nilotinib—Mental disorder—Omeprazole—Barrett's esophagus	0.000633	0.00236	CcSEcCtD
Nilotinib—Malnutrition—Omeprazole—Barrett's esophagus	0.000629	0.00234	CcSEcCtD
Nilotinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.000629	0.00234	CcSEcCtD
Nilotinib—Flatulence—Esomeprazole—Barrett's esophagus	0.000619	0.00231	CcSEcCtD
Nilotinib—Flatulence—Omeprazole—Barrett's esophagus	0.000619	0.00231	CcSEcCtD
Nilotinib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000616	0.00229	CcSEcCtD
Nilotinib—Dysgeusia—Omeprazole—Barrett's esophagus	0.000616	0.00229	CcSEcCtD
Nilotinib—Back pain—Omeprazole—Barrett's esophagus	0.000608	0.00226	CcSEcCtD
Nilotinib—Back pain—Esomeprazole—Barrett's esophagus	0.000608	0.00226	CcSEcCtD
Nilotinib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000604	0.00225	CcSEcCtD
Nilotinib—Muscle spasms—Omeprazole—Barrett's esophagus	0.000604	0.00225	CcSEcCtD
Nilotinib—Vision blurred—Omeprazole—Barrett's esophagus	0.000592	0.00221	CcSEcCtD
Nilotinib—Vision blurred—Esomeprazole—Barrett's esophagus	0.000592	0.00221	CcSEcCtD
Nilotinib—Tremor—Omeprazole—Barrett's esophagus	0.000589	0.00219	CcSEcCtD
Nilotinib—Tremor—Esomeprazole—Barrett's esophagus	0.000589	0.00219	CcSEcCtD
Nilotinib—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000583	0.00217	CcSEcCtD
Nilotinib—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000583	0.00217	CcSEcCtD
Nilotinib—Anaemia—Esomeprazole—Barrett's esophagus	0.000581	0.00216	CcSEcCtD
Nilotinib—Anaemia—Omeprazole—Barrett's esophagus	0.000581	0.00216	CcSEcCtD
Nilotinib—Malaise—Esomeprazole—Barrett's esophagus	0.000567	0.00211	CcSEcCtD
Nilotinib—Malaise—Omeprazole—Barrett's esophagus	0.000567	0.00211	CcSEcCtD
Nilotinib—Vertigo—Omeprazole—Barrett's esophagus	0.000565	0.0021	CcSEcCtD
Nilotinib—Vertigo—Esomeprazole—Barrett's esophagus	0.000565	0.0021	CcSEcCtD
Nilotinib—Leukopenia—Esomeprazole—Barrett's esophagus	0.000563	0.0021	CcSEcCtD
Nilotinib—Leukopenia—Omeprazole—Barrett's esophagus	0.000563	0.0021	CcSEcCtD
Nilotinib—Palpitations—Esomeprazole—Barrett's esophagus	0.000555	0.00207	CcSEcCtD
Nilotinib—Palpitations—Omeprazole—Barrett's esophagus	0.000555	0.00207	CcSEcCtD
Nilotinib—Cough—Omeprazole—Barrett's esophagus	0.000548	0.00204	CcSEcCtD
Nilotinib—Cough—Esomeprazole—Barrett's esophagus	0.000548	0.00204	CcSEcCtD
Nilotinib—Hypertension—Esomeprazole—Barrett's esophagus	0.000543	0.00202	CcSEcCtD
Nilotinib—Hypertension—Omeprazole—Barrett's esophagus	0.000543	0.00202	CcSEcCtD
Nilotinib—Arthralgia—Omeprazole—Barrett's esophagus	0.000535	0.00199	CcSEcCtD
Nilotinib—Myalgia—Esomeprazole—Barrett's esophagus	0.000535	0.00199	CcSEcCtD
Nilotinib—Chest pain—Omeprazole—Barrett's esophagus	0.000535	0.00199	CcSEcCtD
Nilotinib—Myalgia—Omeprazole—Barrett's esophagus	0.000535	0.00199	CcSEcCtD
Nilotinib—Arthralgia—Esomeprazole—Barrett's esophagus	0.000535	0.00199	CcSEcCtD
Nilotinib—Chest pain—Esomeprazole—Barrett's esophagus	0.000535	0.00199	CcSEcCtD
Nilotinib—Anxiety—Esomeprazole—Barrett's esophagus	0.000533	0.00199	CcSEcCtD
Nilotinib—Anxiety—Omeprazole—Barrett's esophagus	0.000533	0.00199	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000531	0.00198	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000531	0.00198	CcSEcCtD
Nilotinib—Discomfort—Omeprazole—Barrett's esophagus	0.000529	0.00197	CcSEcCtD
Nilotinib—Discomfort—Esomeprazole—Barrett's esophagus	0.000529	0.00197	CcSEcCtD
Nilotinib—Dry mouth—Esomeprazole—Barrett's esophagus	0.000523	0.00195	CcSEcCtD
Nilotinib—Dry mouth—Omeprazole—Barrett's esophagus	0.000523	0.00195	CcSEcCtD
Nilotinib—Confusional state—Omeprazole—Barrett's esophagus	0.000517	0.00193	CcSEcCtD
Nilotinib—Confusional state—Esomeprazole—Barrett's esophagus	0.000517	0.00193	CcSEcCtD
Nilotinib—Infection—Esomeprazole—Barrett's esophagus	0.00051	0.0019	CcSEcCtD
Nilotinib—Infection—Omeprazole—Barrett's esophagus	0.00051	0.0019	CcSEcCtD
Nilotinib—Shock—Omeprazole—Barrett's esophagus	0.000505	0.00188	CcSEcCtD
Nilotinib—Shock—Esomeprazole—Barrett's esophagus	0.000505	0.00188	CcSEcCtD
Nilotinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000503	0.00187	CcSEcCtD
Nilotinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000503	0.00187	CcSEcCtD
Nilotinib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000502	0.00187	CcSEcCtD
Nilotinib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000502	0.00187	CcSEcCtD
Nilotinib—Tachycardia—Omeprazole—Barrett's esophagus	0.000501	0.00186	CcSEcCtD
Nilotinib—Tachycardia—Esomeprazole—Barrett's esophagus	0.000501	0.00186	CcSEcCtD
Nilotinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000498	0.00186	CcSEcCtD
Nilotinib—Skin disorder—Omeprazole—Barrett's esophagus	0.000498	0.00186	CcSEcCtD
Nilotinib—CYP3A4—digestive system—Barrett's esophagus	0.000496	0.00429	CbGeAlD
Nilotinib—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000496	0.00185	CcSEcCtD
Nilotinib—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000496	0.00185	CcSEcCtD
Nilotinib—Anorexia—Esomeprazole—Barrett's esophagus	0.000489	0.00182	CcSEcCtD
Nilotinib—Anorexia—Omeprazole—Barrett's esophagus	0.000489	0.00182	CcSEcCtD
Nilotinib—CYP2D6—digestive system—Barrett's esophagus	0.000488	0.00422	CbGeAlD
Nilotinib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000467	0.00174	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000467	0.00174	CcSEcCtD
Nilotinib—Insomnia—Omeprazole—Barrett's esophagus	0.000464	0.00173	CcSEcCtD
Nilotinib—Insomnia—Esomeprazole—Barrett's esophagus	0.000464	0.00173	CcSEcCtD
Nilotinib—ABCB1—epithelium—Barrett's esophagus	0.000462	0.00399	CbGeAlD
Nilotinib—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000461	0.00172	CcSEcCtD
Nilotinib—Paraesthesia—Omeprazole—Barrett's esophagus	0.000461	0.00172	CcSEcCtD
Nilotinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000457	0.0017	CcSEcCtD
Nilotinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000457	0.0017	CcSEcCtD
Nilotinib—Dyspepsia—Omeprazole—Barrett's esophagus	0.000452	0.00168	CcSEcCtD
Nilotinib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000452	0.00168	CcSEcCtD
Nilotinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000446	0.00166	CcSEcCtD
Nilotinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000446	0.00166	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000443	0.00165	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000443	0.00165	CcSEcCtD
Nilotinib—Fatigue—Omeprazole—Barrett's esophagus	0.000442	0.00165	CcSEcCtD
Nilotinib—Fatigue—Esomeprazole—Barrett's esophagus	0.000442	0.00165	CcSEcCtD
Nilotinib—Pain—Esomeprazole—Barrett's esophagus	0.000439	0.00163	CcSEcCtD
Nilotinib—Constipation—Omeprazole—Barrett's esophagus	0.000439	0.00163	CcSEcCtD
Nilotinib—Constipation—Esomeprazole—Barrett's esophagus	0.000439	0.00163	CcSEcCtD
Nilotinib—Pain—Omeprazole—Barrett's esophagus	0.000439	0.00163	CcSEcCtD
Nilotinib—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000423	0.00157	CcSEcCtD
Nilotinib—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000423	0.00157	CcSEcCtD
Nilotinib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000419	0.00156	CcSEcCtD
Nilotinib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000419	0.00156	CcSEcCtD
Nilotinib—Urticaria—Esomeprazole—Barrett's esophagus	0.000408	0.00152	CcSEcCtD
Nilotinib—Urticaria—Omeprazole—Barrett's esophagus	0.000408	0.00152	CcSEcCtD
Nilotinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000406	0.00151	CcSEcCtD
Nilotinib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000406	0.00151	CcSEcCtD
Nilotinib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000406	0.00151	CcSEcCtD
Nilotinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000406	0.00151	CcSEcCtD
Nilotinib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000378	0.00141	CcSEcCtD
Nilotinib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000378	0.00141	CcSEcCtD
Nilotinib—Asthenia—Esomeprazole—Barrett's esophagus	0.000368	0.00137	CcSEcCtD
Nilotinib—Asthenia—Omeprazole—Barrett's esophagus	0.000368	0.00137	CcSEcCtD
Nilotinib—Pruritus—Omeprazole—Barrett's esophagus	0.000363	0.00135	CcSEcCtD
Nilotinib—Pruritus—Esomeprazole—Barrett's esophagus	0.000363	0.00135	CcSEcCtD
Nilotinib—ABCB1—digestive system—Barrett's esophagus	0.000351	0.00304	CbGeAlD
Nilotinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000351	0.00131	CcSEcCtD
Nilotinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000351	0.00131	CcSEcCtD
Nilotinib—Dizziness—Omeprazole—Barrett's esophagus	0.000339	0.00126	CcSEcCtD
Nilotinib—Dizziness—Esomeprazole—Barrett's esophagus	0.000339	0.00126	CcSEcCtD
Nilotinib—Vomiting—Omeprazole—Barrett's esophagus	0.000326	0.00121	CcSEcCtD
Nilotinib—Vomiting—Esomeprazole—Barrett's esophagus	0.000326	0.00121	CcSEcCtD
Nilotinib—Rash—Omeprazole—Barrett's esophagus	0.000323	0.0012	CcSEcCtD
Nilotinib—Rash—Esomeprazole—Barrett's esophagus	0.000323	0.0012	CcSEcCtD
Nilotinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000323	0.0012	CcSEcCtD
Nilotinib—Dermatitis—Omeprazole—Barrett's esophagus	0.000323	0.0012	CcSEcCtD
Nilotinib—Headache—Esomeprazole—Barrett's esophagus	0.000321	0.0012	CcSEcCtD
Nilotinib—Headache—Omeprazole—Barrett's esophagus	0.000321	0.0012	CcSEcCtD
Nilotinib—Nausea—Esomeprazole—Barrett's esophagus	0.000305	0.00113	CcSEcCtD
Nilotinib—Nausea—Omeprazole—Barrett's esophagus	0.000305	0.00113	CcSEcCtD
Nilotinib—MAPK8—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.5e-05	0.000507	CbGpPWpGaD
Nilotinib—MAPK11—Signaling by NGF—RELA—Barrett's esophagus	7.49e-05	0.000505	CbGpPWpGaD
Nilotinib—BRAF—Signaling by NGF—RELA—Barrett's esophagus	7.42e-05	0.000501	CbGpPWpGaD
Nilotinib—ABL1—Cell Cycle—TP53—Barrett's esophagus	7.4e-05	0.0005	CbGpPWpGaD
Nilotinib—CA2—Metabolism—SLC9A1—Barrett's esophagus	7.3e-05	0.000493	CbGpPWpGaD
Nilotinib—MAPK8—Circadian rythm related genes—TP53—Barrett's esophagus	7.2e-05	0.000486	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	7.17e-05	0.000484	CbGpPWpGaD
Nilotinib—BRAF—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	7.15e-05	0.000483	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—GAST—Barrett's esophagus	7.12e-05	0.000481	CbGpPWpGaD
Nilotinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	7.1e-05	0.00048	CbGpPWpGaD
Nilotinib—MAPK14—Cellular Senescence—CXCL8—Barrett's esophagus	7.1e-05	0.00048	CbGpPWpGaD
Nilotinib—ABL1—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	7.02e-05	0.000474	CbGpPWpGaD
Nilotinib—CA1—Metabolism—SLC9A1—Barrett's esophagus	7e-05	0.000473	CbGpPWpGaD
Nilotinib—MAPK14—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	6.89e-05	0.000465	CbGpPWpGaD
Nilotinib—LCK—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	6.78e-05	0.000458	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—GAST—Barrett's esophagus	6.77e-05	0.000457	CbGpPWpGaD
Nilotinib—KIT—Signaling by NGF—RELA—Barrett's esophagus	6.75e-05	0.000456	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTGES—Barrett's esophagus	6.71e-05	0.000453	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.64e-05	0.000448	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—NR1I2—Barrett's esophagus	6.62e-05	0.000447	CbGpPWpGaD
Nilotinib—BRAF—MAPK Signaling Pathway—TP53—Barrett's esophagus	6.56e-05	0.000443	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.46e-05	0.000436	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by NGF—RELA—Barrett's esophagus	6.39e-05	0.000431	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	6.38e-05	0.000431	CbGpPWpGaD
Nilotinib—CA3—Metabolism—PTGS2—Barrett's esophagus	6.31e-05	0.000426	CbGpPWpGaD
Nilotinib—LCK—B Cell Activation—RELA—Barrett's esophagus	6.28e-05	0.000424	CbGpPWpGaD
Nilotinib—MAPK14—Oxidative Stress Induced Senescence—TP53—Barrett's esophagus	6.23e-05	0.000421	CbGpPWpGaD
Nilotinib—BRAF—Disease—SLC9A1—Barrett's esophagus	6.15e-05	0.000415	CbGpPWpGaD
Nilotinib—CA9—Metabolism—SLC9A1—Barrett's esophagus	6.15e-05	0.000415	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—HGF—Barrett's esophagus	6.15e-05	0.000415	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—HGF—Barrett's esophagus	6.13e-05	0.000414	CbGpPWpGaD
Nilotinib—MAPK11—Cellular Senescence—TP53—Barrett's esophagus	6.11e-05	0.000412	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—PPARG—Barrett's esophagus	5.97e-05	0.000403	CbGpPWpGaD
Nilotinib—HCK—Immune System—HGF—Barrett's esophagus	5.94e-05	0.000401	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—CDKN2A—Barrett's esophagus	5.92e-05	0.0004	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—RELA—Barrett's esophagus	5.91e-05	0.000399	CbGpPWpGaD
Nilotinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	5.88e-05	0.000397	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.86e-05	0.000395	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—HGF—Barrett's esophagus	5.83e-05	0.000394	CbGpPWpGaD
Nilotinib—MAPK8—Cellular responses to stress—TP53—Barrett's esophagus	5.79e-05	0.000391	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—RELA—Barrett's esophagus	5.76e-05	0.000389	CbGpPWpGaD
Nilotinib—MAPK14—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	5.74e-05	0.000387	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	5.73e-05	0.000387	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—RELA—Barrett's esophagus	5.7e-05	0.000385	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTGES—Barrett's esophagus	5.69e-05	0.000384	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—GAST—Barrett's esophagus	5.67e-05	0.000383	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—GAST—Barrett's esophagus	5.62e-05	0.000379	CbGpPWpGaD
Nilotinib—KIT—Disease—SLC9A1—Barrett's esophagus	5.6e-05	0.000378	CbGpPWpGaD
Nilotinib—CA9—Cellular responses to stress—TP53—Barrett's esophagus	5.46e-05	0.000369	CbGpPWpGaD
Nilotinib—ABL1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	5.41e-05	0.000365	CbGpPWpGaD
Nilotinib—BLK—Immune System—HGF—Barrett's esophagus	5.38e-05	0.000363	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HGF—Barrett's esophagus	5.38e-05	0.000363	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—CXCL8—Barrett's esophagus	5.37e-05	0.000362	CbGpPWpGaD
Nilotinib—FGR—Immune System—HGF—Barrett's esophagus	5.36e-05	0.000362	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—RELA—Barrett's esophagus	5.36e-05	0.000362	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—RELA—Barrett's esophagus	5.34e-05	0.000361	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—RELA—Barrett's esophagus	5.34e-05	0.000361	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—TP53—Barrett's esophagus	5.32e-05	0.000359	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—SLC9A1—Barrett's esophagus	5.3e-05	0.000358	CbGpPWpGaD
Nilotinib—CA14—Metabolism—PPARG—Barrett's esophagus	5.17e-05	0.000349	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—RELA—Barrett's esophagus	5.15e-05	0.000347	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—GAST—Barrett's esophagus	5.12e-05	0.000345	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.1e-05	0.000345	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TP53—Barrett's esophagus	5.09e-05	0.000344	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CYP26A1—Barrett's esophagus	5.09e-05	0.000343	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—HGF—Barrett's esophagus	5.04e-05	0.000341	CbGpPWpGaD
Nilotinib—CA6—Metabolism—PPARG—Barrett's esophagus	5.04e-05	0.00034	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SST—Barrett's esophagus	4.88e-05	0.00033	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—GAST—Barrett's esophagus	4.84e-05	0.000327	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—RELA—Barrett's esophagus	4.83e-05	0.000326	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—SLC9A1—Barrett's esophagus	4.78e-05	0.000323	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—TP53—Barrett's esophagus	4.73e-05	0.000319	CbGpPWpGaD
Nilotinib—CA7—Metabolism—PPARG—Barrett's esophagus	4.71e-05	0.000318	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	4.7e-05	0.000317	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SST—Barrett's esophagus	4.64e-05	0.000313	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—RELA—Barrett's esophagus	4.62e-05	0.000312	CbGpPWpGaD
Nilotinib—MAPK11—Cellular responses to stress—TP53—Barrett's esophagus	4.62e-05	0.000312	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—PPARG—Barrett's esophagus	4.5e-05	0.000303	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.48e-05	0.000302	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	4.47e-05	0.000302	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—GAST—Barrett's esophagus	4.36e-05	0.000295	CbGpPWpGaD
Nilotinib—CA12—Metabolism—PPARG—Barrett's esophagus	4.36e-05	0.000294	CbGpPWpGaD
Nilotinib—MAPK14—Cellular Senescence—TP53—Barrett's esophagus	4.36e-05	0.000294	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	4.31e-05	0.000291	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HGF—Barrett's esophagus	4.29e-05	0.000289	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.28e-05	0.000289	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—GAST—Barrett's esophagus	4.27e-05	0.000288	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—RELA—Barrett's esophagus	4.27e-05	0.000288	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.27e-05	0.000288	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—PPARG—Barrett's esophagus	4.26e-05	0.000288	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTGES—Barrett's esophagus	4.17e-05	0.000282	CbGpPWpGaD
Nilotinib—HCK—Disease—APC—Barrett's esophagus	4.07e-05	0.000275	CbGpPWpGaD
Nilotinib—CA14—Metabolism—PTGS2—Barrett's esophagus	4.07e-05	0.000275	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—GAST—Barrett's esophagus	4.05e-05	0.000273	CbGpPWpGaD
Nilotinib—CA6—Metabolism—PTGS2—Barrett's esophagus	3.97e-05	0.000268	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SST—Barrett's esophagus	3.89e-05	0.000263	CbGpPWpGaD
Nilotinib—KIT—Immune System—HGF—Barrett's esophagus	3.86e-05	0.000261	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SST—Barrett's esophagus	3.85e-05	0.00026	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—RELA—Barrett's esophagus	3.85e-05	0.00026	CbGpPWpGaD
Nilotinib—LCK—Disease—SLC9A1—Barrett's esophagus	3.83e-05	0.000259	CbGpPWpGaD
Nilotinib—CA7—Metabolism—PTGS2—Barrett's esophagus	3.7e-05	0.00025	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—RELA—Barrett's esophagus	3.7e-05	0.00025	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—SLC9A1—Barrett's esophagus	3.67e-05	0.000247	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HGF—Barrett's esophagus	3.66e-05	0.000247	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—RELA—Barrett's esophagus	3.64e-05	0.000246	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—RELA—Barrett's esophagus	3.64e-05	0.000246	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—RELA—Barrett's esophagus	3.62e-05	0.000245	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.59e-05	0.000242	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	3.53e-05	0.000239	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SST—Barrett's esophagus	3.51e-05	0.000237	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—GAST—Barrett's esophagus	3.5e-05	0.000236	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—RELA—Barrett's esophagus	3.5e-05	0.000236	CbGpPWpGaD
Nilotinib—CA4—Metabolism—PPARG—Barrett's esophagus	3.48e-05	0.000235	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—RELA—Barrett's esophagus	3.45e-05	0.000233	CbGpPWpGaD
Nilotinib—HCK—Immune System—RELA—Barrett's esophagus	3.44e-05	0.000233	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—TP53—Barrett's esophagus	3.43e-05	0.000232	CbGpPWpGaD
Nilotinib—CA12—Metabolism—PTGS2—Barrett's esophagus	3.43e-05	0.000232	CbGpPWpGaD
Nilotinib—CA2—Metabolism—PPARG—Barrett's esophagus	3.33e-05	0.000225	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SST—Barrett's esophagus	3.32e-05	0.000224	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HGF—Barrett's esophagus	3.3e-05	0.000222	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—TP53—Barrett's esophagus	3.29e-05	0.000222	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—RELA—Barrett's esophagus	3.28e-05	0.000222	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.25e-05	0.000219	CbGpPWpGaD
Nilotinib—LYN—Immune System—HGF—Barrett's esophagus	3.23e-05	0.000218	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—RELA—Barrett's esophagus	3.21e-05	0.000217	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HGF—Barrett's esophagus	3.21e-05	0.000217	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—RELA—Barrett's esophagus	3.2e-05	0.000216	CbGpPWpGaD
Nilotinib—CA1—Metabolism—PPARG—Barrett's esophagus	3.2e-05	0.000216	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	3.16e-05	0.000214	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—RELA—Barrett's esophagus	3.15e-05	0.000213	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—RELA—Barrett's esophagus	3.12e-05	0.000211	CbGpPWpGaD
Nilotinib—BLK—Immune System—RELA—Barrett's esophagus	3.12e-05	0.000211	CbGpPWpGaD
Nilotinib—FGR—Immune System—RELA—Barrett's esophagus	3.11e-05	0.00021	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	3.11e-05	0.00021	CbGpPWpGaD
Nilotinib—HCK—Disease—PTGS2—Barrett's esophagus	3.09e-05	0.000209	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—RELA—Barrett's esophagus	3.09e-05	0.000208	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.08e-05	0.000208	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HGF—Barrett's esophagus	3.06e-05	0.000207	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—PPARG—Barrett's esophagus	3.05e-05	0.000206	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—RELA—Barrett's esophagus	3.05e-05	0.000206	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SST—Barrett's esophagus	2.99e-05	0.000202	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SST—Barrett's esophagus	2.93e-05	0.000198	CbGpPWpGaD
Nilotinib—BRAF—Disease—APC—Barrett's esophagus	2.91e-05	0.000197	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	2.9e-05	0.000196	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.88e-05	0.000194	CbGpPWpGaD
Nilotinib—CA9—Metabolism—PPARG—Barrett's esophagus	2.81e-05	0.00019	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SST—Barrett's esophagus	2.78e-05	0.000187	CbGpPWpGaD
Nilotinib—CA4—Metabolism—PTGS2—Barrett's esophagus	2.73e-05	0.000185	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	2.68e-05	0.000181	CbGpPWpGaD
Nilotinib—KIT—Disease—APC—Barrett's esophagus	2.65e-05	0.000179	CbGpPWpGaD
Nilotinib—LCK—Immune System—HGF—Barrett's esophagus	2.64e-05	0.000179	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—RELA—Barrett's esophagus	2.63e-05	0.000178	CbGpPWpGaD
Nilotinib—CA2—Metabolism—PTGS2—Barrett's esophagus	2.62e-05	0.000177	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—APC—Barrett's esophagus	2.58e-05	0.000174	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—RELA—Barrett's esophagus	2.53e-05	0.000171	CbGpPWpGaD
Nilotinib—CA1—Metabolism—PTGS2—Barrett's esophagus	2.51e-05	0.00017	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—APC—Barrett's esophagus	2.51e-05	0.000169	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—RELA—Barrett's esophagus	2.49e-05	0.000168	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—APC—Barrett's esophagus	2.46e-05	0.000166	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SST—Barrett's esophagus	2.4e-05	0.000162	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.33e-05	0.000157	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	2.28e-05	0.000154	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—APC—Barrett's esophagus	2.26e-05	0.000153	CbGpPWpGaD
Nilotinib—KIT—Immune System—RELA—Barrett's esophagus	2.24e-05	0.000151	CbGpPWpGaD
Nilotinib—BRAF—Disease—PTGS2—Barrett's esophagus	2.21e-05	0.000149	CbGpPWpGaD
Nilotinib—CA9—Metabolism—PTGS2—Barrett's esophagus	2.21e-05	0.000149	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.2e-05	0.000148	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—PPARG—Barrett's esophagus	2.18e-05	0.000147	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.18e-05	0.000147	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—RELA—Barrett's esophagus	2.12e-05	0.000143	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—TP53—Barrett's esophagus	2.06e-05	0.000139	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—APC—Barrett's esophagus	2.06e-05	0.000139	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—TP53—Barrett's esophagus	2.06e-05	0.000139	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—APC—Barrett's esophagus	2.04e-05	0.000138	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—RELA—Barrett's esophagus	2.02e-05	0.000136	CbGpPWpGaD
Nilotinib—KIT—Disease—PTGS2—Barrett's esophagus	2.01e-05	0.000136	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.98e-05	0.000134	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—TP53—Barrett's esophagus	1.96e-05	0.000132	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.93e-05	0.00013	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.93e-05	0.00013	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—RELA—Barrett's esophagus	1.92e-05	0.00013	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—RELA—Barrett's esophagus	1.91e-05	0.000129	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—PTGS2—Barrett's esophagus	1.9e-05	0.000129	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CXCL8—Barrett's esophagus	1.9e-05	0.000128	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.9e-05	0.000128	CbGpPWpGaD
Nilotinib—LYN—Immune System—RELA—Barrett's esophagus	1.87e-05	0.000126	CbGpPWpGaD
Nilotinib—ABL1—Immune System—RELA—Barrett's esophagus	1.86e-05	0.000126	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—APC—Barrett's esophagus	1.86e-05	0.000125	CbGpPWpGaD
Nilotinib—LCK—Disease—APC—Barrett's esophagus	1.81e-05	0.000122	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CXCL8—Barrett's esophagus	1.81e-05	0.000122	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—RELA—Barrett's esophagus	1.77e-05	0.00012	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—APC—Barrett's esophagus	1.76e-05	0.000119	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PTGS2—Barrett's esophagus	1.72e-05	0.000116	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TP53—Barrett's esophagus	1.69e-05	0.000114	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.68e-05	0.000114	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PPARG—Barrett's esophagus	1.67e-05	0.000113	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.61e-05	0.000109	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—RELA—Barrett's esophagus	1.61e-05	0.000109	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—RELA—Barrett's esophagus	1.59e-05	0.000108	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.58e-05	0.000107	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—APC—Barrett's esophagus	1.58e-05	0.000107	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.57e-05	0.000106	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.56e-05	0.000105	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—APC—Barrett's esophagus	1.55e-05	0.000105	CbGpPWpGaD
Nilotinib—LCK—Immune System—RELA—Barrett's esophagus	1.53e-05	0.000104	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CXCL8—Barrett's esophagus	1.52e-05	0.000102	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CXCL8—Barrett's esophagus	1.5e-05	0.000101	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—APC—Barrett's esophagus	1.47e-05	9.91e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—RELA—Barrett's esophagus	1.45e-05	9.79e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.44e-05	9.7e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PPARG—Barrett's esophagus	1.42e-05	9.58e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—PTGS2—Barrett's esophagus	1.38e-05	9.29e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—RELA—Barrett's esophagus	1.37e-05	9.26e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CXCL8—Barrett's esophagus	1.37e-05	9.22e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PTGS2—Barrett's esophagus	1.32e-05	8.89e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CXCL8—Barrett's esophagus	1.29e-05	8.73e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—APC—Barrett's esophagus	1.27e-05	8.57e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.27e-05	8.55e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—RELA—Barrett's esophagus	1.24e-05	8.35e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—RELA—Barrett's esophagus	1.21e-05	8.17e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TP53—Barrett's esophagus	1.17e-05	7.88e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CXCL8—Barrett's esophagus	1.17e-05	7.87e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—RELA—Barrett's esophagus	1.15e-05	7.75e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CXCL8—Barrett's esophagus	1.14e-05	7.7e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	1.12e-05	7.54e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TP53—Barrett's esophagus	1.11e-05	7.49e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CXCL8—Barrett's esophagus	1.08e-05	7.3e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PPARG—Barrett's esophagus	1.04e-05	7.03e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.04e-05	6.99e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RELA—Barrett's esophagus	9.92e-06	6.7e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CXCL8—Barrett's esophagus	9.35e-06	6.31e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TP53—Barrett's esophagus	9.3e-06	6.28e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TP53—Barrett's esophagus	9.21e-06	6.22e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	8.81e-06	5.95e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TP53—Barrett's esophagus	8.38e-06	5.66e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	8.19e-06	5.53e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TP53—Barrett's esophagus	7.94e-06	5.36e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	7.68e-06	5.18e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	7.23e-06	4.88e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PPARG—Barrett's esophagus	7.17e-06	4.84e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TP53—Barrett's esophagus	7.15e-06	4.83e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TP53—Barrett's esophagus	7e-06	4.73e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	6.93e-06	4.68e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TP53—Barrett's esophagus	6.64e-06	4.48e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	6.04e-06	4.08e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TP53—Barrett's esophagus	5.74e-06	3.87e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	5.69e-06	3.84e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	5.64e-06	3.81e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.73e-06	3.19e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.72e-06	2.51e-05	CbGpPWpGaD
